CD38 Pretargeted Radioimmunotherapy for Myeloma

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Multiple myeloma and immunoproliferative diseases

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Steven M Lipkin

Whole Genome Sequencing to Discover Familial Myeloma Risk Genes

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Ratneshwar Lal

Amyloid ion channels to design therapeutics for neurodegenerative diseases

Multiple myeloma and immunoproliferative diseases

Pathology

Irene M. Ghobrial

The role of miRNA15a and 16-1 in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Ruben D Carrasco

Validating the eCyPA/CD147 signaling complex for myeloma therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Robert L Comis

ECOG-ACRIN Operations Center

Trachea, bronchus and lung Prostate Pancreas Non-Hodgkin lymphoma Nasopharynx Multiple myeloma and immunoproliferative diseases Melanoma of skin Leukaemia Colorectum Breast Bladder